At a glance
- Originator Ono Pharmaceutical
- Class Antiplatelets
- Mechanism of Action Platelet aggregation inhibitors; Prostaglandin agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 22 Sep 1998 No-Development-Reported for Thrombosis in Japan (Unknown route)
- 15 May 1995 New profile
- 15 May 1995 Preclinical development for Thrombosis in Japan (Unknown route)